Patricia Harnden

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

Edgars Celms, Martins Opmanis, Andris Zarins, 2014, Nature Communications.

Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression

Rosamonde E Banks, C. Taylor, P. Selby, 2005, Clinical Cancer Research.

Urinary biomarker profiling in transitional cell carcinoma

Ian Eardley, David A Cairns, Douglas Thompson, 2006, International journal of cancer.

Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma

Rosamonde E Banks, D. Pappin, D. Rahman, 2003, Proteomics.

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

Ananya Choudhury, D. Bishop, R. Bristow, 2010, Cancer research.

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

Paolo Vineis, Salvatore Panico, Vittorio Krogh, 2011, Nature Genetics.

Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma

Richard Unwin, Ian Eardley, Rosamonde E Banks, 2006, Proteomics.

The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?

Bernadette Coles, M. Mason, M. Shelley, 2008, Cancer.